EXC

EXC - Exelon Corp

BUYAWAIT ENTRY2026-08-11Data 12 days oldUSD 44.86
68
Conviction
out of 100

Executive Summary

Exelon Corporation (EXC) is a US-based utility services holding company that owns and operates regulated electricity transmission and distribution (T&D) businesses, serving residential, commercial, industrial, public authority and electric railroad customers across its service territories. Following the separation of its generation subsidiary in 2022, Exelon now sits as a pure-play regulated T&D operator, a structural simplification that anchors the post-spin investment proposition.

The investment case rests on stable, regulated cash flows from transmission and distribution, supported by a hard catalyst of USD1 billion in transmission agreements and reaffirmed company guidance. Near-term focus is on execution against those transmission agreements and continued rate-case outcomes, while the primary risk is material adverse regulatory developments arising from issuer filings. We view the transmission contract flow as a more durable positive driver than softer macro commentary on utility multiples.

Bottom line: BUY. Conviction Score: 68/100. The view would be upgraded on confirmation of additional transmission capex authorisations or constructive rate-case outcomes and would be downgraded if regulator-led disallowances on transmission spend or material rate-base erosion were to crystallise.

Wait for entry. Current price USD 44.86 is 5.1% above the buy ceiling of USD 42.67. New positions only below the ceiling.
AWAIT ENTRYBUY · 68/100Now USD 44.86 · buy ≤ USD 42.67 · trim ≥ USD 48.00

Thesis break: Material regulator-led disallowance on transmission capex, an adverse outcome in a major rate case that significantly compresses allowed ROE, or a multi-year earnings reset that breaks the reaffirmed guidance trajectory.

Business Model

Exelon generates revenue primarily through regulated rates charged for the transmission and distribution of electricity across the service territories of its six local utility subsidiaries (Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO and Pepco). Revenue is largely a function of approved rate base, allowed return on equity set by state public utility commissions, and volumetric or fixed distribution charges. Following the 2022 spin-off of Constellation Energy, the group no longer owns competitive generation, so the earnings stream is anchored in regulated utility economics rather than commodity-exposed power generation.

Customers are split across residential households, commercial and industrial (C&I) businesses, public sector authorities and electric railroad users, with the mix varying by subsidiary and state. Distribution tariffs recover a combination of fixed customer charges and volumetric delivery components, while transmission revenues are recovered under regional transmission organisation (RTO) formula-rate structures that adjust annually for capital investment and operating costs. This regulated construct produces relatively predictable cash flows insulated from wholesale power prices, although it is exposed to regulatory outcomes, rate-case cycles and weather variability.

The competitive moat, to the extent one exists for a regulated utility, lies in the franchise rights and exclusive service territory concessions granted to each operating subsidiary, plus the scale of the rate base and the recurring nature of regulated capex programmes. Profitability is governed by allowed ROE and rate-base growth rather than market share, and the value driver going forward is incremental transmission and distribution capex approved by regulators and recovered through rate base.

Financial Snapshot

Price
USD 44.86
Market Cap
USD 46.3bn
P/E Ratio
16.4x
52w High
USD 50.65
52w Low
USD 42.58
Distance from 52wH
-11.4%
Beta
0.30
Avg Volume
8944826
Currency
USD

Recent Catalysts

[30 July 2026] - Exelon reported second-quarter 2026 earnings with EPS of USD0.43 versus consensus of USD0.49, a miss on the bottom line. Source: Public.com earnings summary referencing the company report.

[2026 (year-to-date)] - Exelon reaffirmed full-year guidance, supporting the post-spin regulated T&D earnings stream. Source: Analyst commentary aggregated on MarketBeat.

[2026 (year-to-date)] - Exelon secured USD1 billion in transmission agreements referenced as a hard catalyst for the thesis, providing visibility on regulated capex recovery. Source: Analyst commentary aggregated on MarketBeat.

[As of 10 August 2026] - Trailing total return data through 10 August 2026 reflects year-to-date share-price performance within a 52-week range of USD42.58 to USD50.65. Source: Yahoo Finance price and returns page.

[2026 (year-to-date)] - Post-Constellation spin positioning has been reiterated in company materials, with Exelon framed as a pure-play regulated T&D operator. Source: Exelon newsroom and investor communications.

Thesis Evaluation

Bull Case (37% weight)

Transmission capex executes on schedule, additional rate-case wins expand allowed ROE and rate base, and the USD1 billion in transmission agreements is supplemented by further awards within twelve months. Stable regulated earnings growth and a re-rating towards sector utility multiples support a price target of 52.00 over twelve months.

Base Case (47% weight)

Regulated earnings track reaffirmed guidance, the USD1 billion transmission agreement delivers on schedule, and rate-case outcomes broadly offset regulatory headwinds. P/E remains anchored around the current mid-teens reading, with dividend yield providing a return floor and supporting a price target of 48.00 over twelve months.

Bear Case (16% weight)

Regulator-led disallowances on transmission spend, an adverse outcome in a major rate case, or a step-down in allowed ROE compress earnings and rate-base growth assumptions. Multiple contraction towards the low end of the regulated utility range drives a price target of 40.00 over twelve months.

Weighted conviction:Bull (37%) x 100 + Base (47%) x 62 + Bear (16%) x 10 = 68/100. BUY.

Key Risks

  1. Adverse regulatory disallowance on transmission capex: State public utility commissions or FERC could disallow portions of transmission capex from rate base, directly reducing the recoverable earnings stream. Estimated probability: 25%. Impact: severe.
  2. Unfavourable rate-case outcome: A material reduction in allowed return on equity or rate-base treatment in a major subsidiary rate case would compress regulated earnings. Estimated probability: 30%. Impact: moderate.
  3. Refinancing and interest-rate risk: Higher long-end US rates raise the cost of debt funding the regulated capex programme and reduce the present value of future regulated earnings. Estimated probability: 35%. Impact: moderate.
  4. Storm and weather-related operating risk: Severe weather events across Exelon's service territories can drive incremental O&M and restoration costs that are not always fully recovered through regulatory mechanisms. Estimated probability: 40%. Impact: moderate.
  5. Dividend sustainability: A sustained earnings shortfall versus guidance could pressure the payout ratio and investor perception of dividend coverage. Estimated probability: 20%. Impact: low.
  6. Equity issuance or dilution: Exelon could issue equity to fund capex if balance-sheet metrics tighten, diluting existing shareholders. Estimated probability: 15%. Impact: low.

Who Should Own It / Avoid It

Ideal for: Income-oriented, risk-tolerant investors with a minimum holding period of three to five years who want regulated utility exposure with a transmission-capex growth tilt. The investor should be comfortable with single-digit to low-teens annual total return potential, sensitivity to US interest rates and regulatory outcomes, and reliance on dividend income as a meaningful component of return. A medium risk tolerance is appropriate, recognising that regulated utilities are lower-volatility than the broader market but still carry cycle, rate-case and refinancing risk.

Avoid if: Investors requiring rapid capital appreciation, those unable to tolerate a multi-year holding period through regulatory cycles, or investors with low risk tolerance who cannot accept interim mark-to-market drawdowns from interest-rate moves should not hold this stock. Speculative investors looking for short-term catalysts, or those seeking pure-play commodity-linked power exposure, are not the target holder for a regulated T&D operator of Exelon's profile.

Recommendation

BUY - 68/100. The recommendation reflects a constructive stance on regulated cash-flow stability, a hard USD1 billion transmission catalyst, and reasonable valuation at the current P/E, partially offset by material regulatory risk flagged in issuer filings. The call would be upgraded on additional transmission capex authorisations, constructive rate-case outcomes and a multi-year ROE uplift at one or more subsidiaries, and would be downgraded on regulator-led disallowances on transmission spend, an adverse major rate-case decision, or evidence of structural ROE compression across the portfolio. At the current price of $44.86 the shares trade above our buy ceiling of $42.67: the thesis is credible but the price is not - new positions only below that level.

The probability-weighted value across our three scenarios is $48.20, 7% above the current price of $44.86 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $42.67 - below this level the upside to the base-case target ($48.00) is at least 2x the downside to the bear case ($40.00), the minimum risk/reward we require before committing new capital.

HOLD

between $42.67 and $48.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $48.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 37%.

SELL

if material regulator-led disallowance on transmission capex, an adverse outcome in a major rate case that significantly compresses allowed ROE, or a multi-year earnings reset that breaks the reaffirmed guidance trajectory, regardless of price - the bear target of $40.00 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 68/100. Trend versus prior report: Initiation.

CONVBUYOPPSPECAVOID1007550250Conviction (0-100)2026-08-11
CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)
Report dateConviction
2026-08-1168

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: Public news flow, company earnings releases and earnings call transcripts, regulatory filings, investor day materials, and third-party financial news commentary aggregated through public web research.

Primary source types: SEC filings, earnings call transcripts, company press releases, investor relations materials, regulatory announcements, and third-party equity research summaries.

Key sources

Data correct as of 2026-08-11